A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections.

Summary

Using low-dose intranasal inoculation in tlr4 mutant mice, the authors created a chronic A. baumannii pneumonia model lasting ≥3 weeks. The model revealed a stage-specific virulence role for the adhesin InvL, distinguished antibiotics that sterilize versus allow persister formation, and showed polymicrobial effects: S. aureus worsened disease, while K. pneumoniae facilitated clearance.

Key Findings

• Established a chronic A. baumannii pneumonia model in tlr4 mutant mice using low intranasal inocula with infections lasting ≥3 weeks.
• Identified adhesin InvL as required during late infection stages but dispensable early.
• Differentiated antibiotics that clear infection versus those associated with potential persister formation.
• Demonstrated polymicrobial effects: Staphylococcus aureus exacerbated infection, while Klebsiella pneumoniae enhanced clearance.

Clinical Implications

Though preclinical, the model provides a platform to evaluate antibiotics for persistence, identify late-stage virulence targets (e.g., InvL), and understand how coinfections modulate disease—informing therapeutic strategies and stewardship.

Limitations

• Use of tlr4 mutant mice may limit generalizability to immunocompetent hosts.
• Preclinical findings require validation in clinical isolates and human-relevant systems.

Future Directions

Apply the model to test combination therapies against persisters, validate InvL and other late-stage targets, and dissect host–pathogen–coinfection dynamics to inform clinical strategies.